Matinas BioPharma

-$0.0308 (-3.62%) Today
-$0.04 (-4.88%) As of 12:24 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable.

CEO
Jerome D. Jabbour
Employees
20
Headquarters
Bedminster, New Jersey
Founded
2013

MTNB Key Statistics

Market cap
177.32M
Price-Earnings ratio
—
Dividend yield
—
Average volume
797.79K
High today
$0.86
Low today
$0.80
Open price
$0.85
Volume
1.35M
52 Week high
$1.73
52 Week low
$0.6675

MTNB Earnings

-$0.03
-$0.02
-$0.01
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure